Combined with an overexpression of TRIP12, a frequent loss of NPM nucleolar localization strongly impedes the activation of the ARF/P53 pathway in AML-derived cells and favors their proliferation. This evidence concerns the gene TRIP12 and acute myeloid leukemia.